Difficulty: Medium
Average Score: 82%
Testbank
A pharmaceutical company has developed a new medicine that was costly to create. How will the company be compensated for the cost of their research and development?
Correct answer
D
Rationale
They will be allowed to sell the medication with no competition for approximately 10 years. This exclusivity period, often referred to as a patent, allows the pharmaceutical company to recoup its significant investment in research and development by maximizing profits without the pressure of generic competitors entering the market.
A: They will set the price of the medication very high to allow rebates from insurance companies. While high pricing may occur, it does not guarantee compensation for R&D costs, as rebates can reduce the effective price received.
B: They will be awarded money from the government for developing a new medicine. Government funding is not a standard method for compensating pharmaceutical companies; rather, companies rely on market exclusivity and sales to recover their costs.
C: They will get a portion of the payments that other companies receive when they sell the drug. This scenario is unlikely, as pharmaceutical companies typically do not share revenues with others; they profit from their own sales exclusively during the patent period.
A: They will set the price of the medication very high to allow rebates from insurance companies. While high pricing may occur, it does not guarantee compensation for R&D costs, as rebates can reduce the effective price received.
B: They will be awarded money from the government for developing a new medicine. Government funding is not a standard method for compensating pharmaceutical companies; rather, companies rely on market exclusivity and sales to recover their costs.
C: They will get a portion of the payments that other companies receive when they sell the drug. This scenario is unlikely, as pharmaceutical companies typically do not share revenues with others; they profit from their own sales exclusively during the patent period.